| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2024―Okt―22 |
Interaction of SARS-CoV-2 Spike protein with ACE2 induces cortical actin modulation, including dephosphorylation of ERM proteins and reduction of cortical stiffness |
Thi Ly Do, Kouichi Tachibana, Norio Yamamoto, Kiyoshi Ando, Takaaki Isoda, Takanori Kihara |
| 2 |
[GO] |
2024―Mrz―12 |
Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the “Uncontrolled” in SARS-CoV-2 |
K. I. Papadopoulos, A. Papadopoulou, T. C. Aw |
| 3 |
[GO] |
2023―Sep―21 |
The effect of SARS-CoV-2 on the development of Parkinson's disease: the role of α-synuclein |
Farideh Iravanpour, Majid Reza Farrokhi, Morteza Jafarinia, Razieh Tavakoli Oliaee |
| 4 |
[GO] |
2023―Jul―18 |
Interplay between LPL and GPIHBP1 in COVID-19 patients: a possible mechanism for post-recovery cardiomyopathy |
Mohnad Abdalla, Amr Ahmed El-Arabey, Zhongtao Gai |
| 5 |
[GO] |
2023―Jun―12 |
Eight influenza virus cellular manipulations which can boost concurrent SARS-CoV-2 infections to severe outcomes |
Kevin Roe |
| 6 |
[GO] |
2023―Apr―04 |
Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern? |
Ryan Varghese, Dileep Kumar, Rohit Sharma |
| 7 |
[GO] |
2023―Feb―27 |
Beauty and the beast: host microRNA-155 versus SARS-CoV-2 |
K. I. Papadopoulos, A. Papadopoulou, T. C. Aw |
| 8 |
[GO] |
2022―Dez―18 |
Roles of RNA-binding proteins in neurological disorders, COVID-19, and cancer |
Daniel Ruben Akiola Sanya, Claudia Cava, Djamila Onésime |
| 9 |
[GO] |
2022―Okt―10 |
SARS-CoV-2 and Toxoplasma gondii shared symptoms suggest muscle cells and neurons are their chronic infection reservoirs |
Kevin Roe |
| 10 |
[GO] |
2022―Jul―13 |
Hypoxia-inducible factor 1 alpha (HIF-1α) stimulated and P2X7 receptor activated by COVID-19, as a potential therapeutic target and risk factor for epilepsy |
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi-Afjadi, Razieh Forghaniesfidvajani, Chanour Tavakol, Zohreh Barzegar, Farideh Iravanpour, Mahshid Hosseini, Seyed Reza Mousavi, Majid Reza Farrokhi |
| 11 |
[GO] |
2022―Mai―31 |
Flt3-ITD mutated acute myeloid leukemia patients and COVID-19: potential roles of autophagy and HIF-1α in leukemia progression and mortality |
Hamidreza Zalpoor, Mahnaz Rezaei, Sheida Yahyazadeh, Mazdak Ganjalikhani-Hakemi |
| 12 |
[GO] |
2022―Mai―09 |
Increased neuropilin-1 expression by COVID-19: a possible cause of long-term neurological complications and progression of primary brain tumors |
Hamidreza Zalpoor, Hooriyeh Shapourian, Abdullatif Akbari, Shaghayegh Shahveh, Leila Haghshenas |
| 13 |
[GO] |
2022―Apr―04 |
Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID-19 and associated cancers and diseases |
Hamidreza Zalpoor, Abdullatif Akbari, Mohsen Nabi-Afjadi |
| 14 |
[GO] |
2021―Sep―30 |
Mesenchymal stromal cells coated with anti-ACE2 antibodies might improve efficacy against COVID-19 |
Nourhan Saied Bakry, Mai Abdelgawad, Ahmed Abdel-Latif, Ahmed Lotfy |
| 15 |
[GO] |
2021―Sep―24 |
Risk factors for recurrent positive results of the nucleic acid amplification test for COVID-19 patients: a retrospective study |
Wanwan Yi, Xuan Long, Jin Liu, LiShuai Shi, Zichen Chen, Jing Yang, Ziyu Yang, Zhongwei Lv, Hengwei Fan |
| 16 |
[GO] |
2021―Sep―15 |
Efficacy of IL-6 antagonists in the treatment of COVID-19 patients: further randomized controlled trials are warranted |
Aditya K. Panda, Sunali Padhi, Abhijit Pati, Tapan Kumar Singh Nayak |
| 17 |
[GO] |
2021―Aug―27 |
Neurological effects of elevated levels of angiotensin II in COVID-19 patients |
Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji |
| 18 |
[GO] |
2021―Aug―23 |
Association of rs11549465 (C1772T) variant of hypoxia-inducible factor-1α with Covid-19 susceptibility. A population-based epidemiological study |
Anamika Das, Maheswari Patra, Gunanidhi Dhangadamajhi |
| 19 |
[GO] |
2021―Aug―18 |
Association of ApoE isoforms with COVID-19 outcomes: a world-wide epidemiological study |
Gunanidhi Dhangadamajhi, Swayamparna Mishra, Payal Mukherjee |
| 20 |
[GO] |
2021―Jun―16 |
Smoking habits and risk of COVID-19 |
Marco Rossato |
| 21 |
[GO] |
2021―Jun―03 |
Correction to: Smoking habits correlate with the defense against SARS-CoV-2 infection in the Indian population |
Bishwaranjan Purohit, Aditya K. Panda |
| 22 |
[GO] |
2021―Mai―17 |
Smoking habits correlate with the defense against SARS-CoV-2 infection in the Indian population |
Bishwaranjan Purohit, Aditya K. Panda |
| 23 |
[GO] |
2021―Apr―13 |
Neuropilin-1 may be responsible for retinal findings in patients with COVID-19 |
Amr Ahmed El-Arabey, Mohnad Abdalla |
| 24 |
[GO] |
2021―Apr―12 |
TLR3 (rs3775291) variant is not associated with SARS-CoV-2 infection and related mortality: a population-based correlation analysis |
Abhijit Pati, Sunali Padhi, Sanskruti Chaudhury, Aditya K. Panda |
| 25 |
[GO] |
2021―Mrz―07 |
COVID-19 vaccines: rapid development, implications, challenges and future prospects |
Shivaji Kashte, Arvind Gulbake, Saadiq F. El-Amin III, Ashim Gupta |
| 26 |
[GO] |
2021―Feb―22 |
Association of TLR3 functional variant (rs3775291) with COVID-19 susceptibility and death: a population-scale study |
Gunanidhi Dhangadamajhi, Ronnaly Rout |
| 27 |
[GO] |
2021―Feb―18 |
Clinical features and prognostic factors of patients with COVID-19 in Henan Province, China |
Qianqian Zhang, Zheng Wang, Yanping Lv, Jiang Zhao, Qiang Dang, Dongfeng Xu, Dongxiang Zhao, Haiyang Liu, Ziqi Wang, Xingru Zhao, Zhiwei Xu, Xiaoju Zhang |
| 28 |
[GO] |
2021―Feb―01 |
mTOR inhibition: a double-edged sword in patients with COVID-19? |
Morteza Ghasemnejad-Berenji |
| 29 |
[GO] |
2021―Jan―25 |
ACE2 mutation might explain lower COVID-19 burden in malaria endemic areas |
Auley De, Aparna Tiwari, Manoswini Dash, Abhinav Sinha |
| 30 |
[GO] |
2021―Jan―12 |
PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19 |
Mohammad Rafi Khezri |
| 31 |
[GO] |
2020―Okt―09 |
Umbilical cord: an allogenic tissue for potential treatment of COVID-19 |
Hugo C. Rodriguez, Manu Gupta, Emilio Cavazos-Escobar, Saadiq F. El-Amin, Ashim Gupta |
| 32 |
[GO] |
2020―Aug―11 |
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective |
Ashim Gupta, Shivaji Kashte, Manu Gupta, Hugo C. Rodriguez, Shraddha Singh Gautam, Sachin Kadam |
